SENZELVI

EUIPO EUIPO 2019 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark SENZELVI was filed as Word mark on 01/21/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/17/2019. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 29, 2019

Trademark form Word mark
File reference 018012996
Application date January 21, 2019
Publication date April 9, 2019
Entry date July 17, 2019
Expiration date January 21, 2029

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; pharmaceutical preparations; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Trademark history

Date Document number Area Entry
October 8, 2019 Change Representative, Notified

ID: 11018012996